Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $103.07.
Several brokerages have recently commented on CAH. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. Barclays initiated coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price objective for the company. UBS Group boosted their target price on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a report on Monday, February 5th. SVB Leerink began coverage on Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 price target for the company. Finally, StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday.
Get Our Latest Analysis on Cardinal Health
Institutional Investors Weigh In On Cardinal Health
Cardinal Health Stock Performance
NYSE CAH opened at $103.54 on Monday. Cardinal Health has a twelve month low of $77.56 and a twelve month high of $116.04. The stock has a market cap of $25.18 billion, a PE ratio of 40.76, a PEG ratio of 0.99 and a beta of 0.68. The firm has a 50-day simple moving average of $109.56 and a 200 day simple moving average of $104.59.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.26. The business had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.32 EPS. Research analysts forecast that Cardinal Health will post 7.28 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.93%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is 78.74%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- Most Volatile Stocks, What Investors Need to Know
- High-Yield Texas Instruments Could Hit New Highs Soon
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Consumer Staples Stocks, Explained
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.